Explore the Future of Brain Stimulation

at the International Brain Stimulation Conference 2027

Lyon, France | February 2027

MagVenture will participate in the International Brain Stimulation Conference in Lyon, France, in February 2027 as platinum sponsor.

As part of the official scientific program, we will host a series of educational sessions at the International Brain Stimulation Conference 2027, bringing together leading researchers and clinicians to share scientific knowledge, emerging research and practical experience in brain stimulation.
These sessions will provide attendees with insights into next-generation TMS technologies, advances in personalized and accelerated treatment approaches, and the future of convulsive therapy (MST).

Explore the workshops below to learn more about each session and register to attend.
We look forward to seeing you in Lyon.

Audience raising their hands during a presentation
Feb 21th WORKSHOP – FULL DAY

NEXT WAVE OF CONVULSIVE THERAPY USING MAGVENTURE MST TECHNOLOGY*

Hear from Prof. Daniel Blumberger, Prof. André Brunoni, Prof. Zafiris Daskalakis and Dr. Eric Cretaz as they explore current MST research and future perspectives.

The program includes scientific discussion as well as a limited-capacity hands-on educational session.

The two workshops have been intentionally designed as a connected program, with the morning session providing the scientific foundation that naturally flows into the hands-on workshop in the afternoon.

Attend the full-day MST educational experience: Learn the science in the morning. Gain practical expertise in the afternoon.

*MST technology presented during this workshop is not currently available for commercial clinical use.

Audience listening to a speaker at a workshop
Feb 22nd – WORKSHOP
7:30 – 8:30

NEXT-GEN TMS TECHNOLOGY

Personalization, accelerated, precision-enabled TMS

Join MagVenture for a forward-looking educational session on the next generation of TMS – built for the demands of modern clinical and research workflows.

Drawing on 35 years of TMS manufacturing craftsmanship, we will explore how technology is evolving to support a new era of acceleration, precision, and personalization.

Professor Brunoni will share perspectives on how accelerated protocols and increasing requirements for treatment efficiency are shaping what is needed from tomorrow’s TMS systems.

Discover how the next gen MagVenture technology platform will unlock new frontiers in effective, reliable and advanced TMS – and experience a glimpse of what comes next for the technology at the very heart of every TMS treatment – the magnetic stimulation itself.

Audience seated in a conference room
Feb 23rd – WORKSHOP
7:30 – 8:30

FUTURE OF CONVULSIVE THERAPY- MAGNETIC SEIZURE THERAPY

If you are unable to attend the more extensive MST educational program on Sunday, 21 February, join us two days later for a one-hour overview highlighting key topics in MST science, technology and emerging clinical evidence.

This condensed session will provide an introduction to Magnetic Seizure Therapy, a demonstration of the technology, and highlights from clinical research.

Speakers:

  • Lilja Gudmundsdottir Astrup, MST Program Lead, MagVenture
  • Matthias Kienle, Head of International Business Development, Medical Affairs, MagVenture

Educational content. For healthcare professionals only.
MagVenture Educate provides scientific and educational information for healthcare professionals.

MST is investigational, and other topics discussed during this session may involve emerging, investigational or non-approved applications depending on the applicable regulatory status in your region.

The session is provided for educational purposes only and is not intended as product promotion or guidance for clinical use.

Hands-on participation is intended for educational and technology-familiarization purposes and does not by itself constitute authorization, qualification or competency for clinical use.

Skip to content